Back to today’s briefing

Story perspectives

Novavax Vaccine Approved Abroad; U.S. Faces Major Setback

4/27/2025

50 8

Summary

Story summary

Novavax's Covid-19 vaccine has gained approval in Europe, Japan, and Australia, sparking hope for global vaccination efforts. However, U.S. regulators have thrown a wrench in the works, demanding a costly new clinical trial. This unexpected hurdle, influenced by Health Secretary Robert F. Kennedy Jr.'s team, raises concerns about the future of vaccine approvals in the U.S.

1 of 1

Story summary

Novavax's Covid-19 vaccine has gained approval in Europe, Japan, and Australia, sparking hope for global vaccination efforts. However, U.S. regulators have thrown a wrench in the works, demanding a costly new clinical trial. This unexpected hurdle, influenced by Health Secretary Robert F. Kennedy Jr.'s team, raises concerns about the future of vaccine approvals in the U.S.